-
1
-
-
66749088102
-
Detection of mosaic RB1 mutations in families with retinoblastoma
-
Rushlow D, Piovesan B, Zhang K, et al. Detection of mosaic RB1 mutations in families with retinoblastoma. Hum Mutat 2009;30:842-851.
-
(2009)
Hum Mutat
, vol.30
, pp. 842-851
-
-
Rushlow, D.1
Piovesan, B.2
Zhang, K.3
-
2
-
-
54549108740
-
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
-
Cancer Genome Atlas Research Network
-
Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-1068.
-
(2008)
Nature
, vol.455
, pp. 1061-1068
-
-
-
4
-
-
67349272856
-
Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK- precursors
-
López-Terrada D, Gunaratne PH, Adesina AM, et al. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK- precursors. Hum Pathol 2009;40: 783-794.
-
(2009)
Hum Pathol
, vol.40
, pp. 783-794
-
-
López-Terrada, D.1
Gunaratne, P.H.2
Adesina, A.M.3
-
5
-
-
33749188496
-
Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?
-
DOI 10.1002/pbc.20698
-
Aretz S, Koch A, Uhlhaas S, et al. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations? Pediatr Blood Cancer 2006;47:811-818. (Pubitemid 44476759)
-
(2006)
Pediatric Blood and Cancer
, vol.47
, Issue.6
, pp. 811-818
-
-
Aretz, S.1
Koch, A.2
Uhlhaas, S.3
Friedl, W.4
Propping, P.5
Von Schweinitz, D.6
Pietsch, T.7
-
6
-
-
37549052178
-
Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations
-
Curia MC, Zuckermann M, De Lellis L, et al. Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations. Mod Pathol 2008;21:7-14.
-
(2008)
Mod Pathol
, vol.21
, pp. 7-14
-
-
Curia, M.C.1
Zuckermann, M.2
De Lellis, L.3
-
7
-
-
77953485589
-
Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations
-
Sugimoto Y, Muramatsu H, Makishima H, et al. Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations. Br J Haematol 2010;150:83-87.
-
(2010)
Br J Haematol
, vol.150
, pp. 83-87
-
-
Sugimoto, Y.1
Muramatsu, H.2
Makishima, H.3
-
8
-
-
46449092873
-
Hereditary colorectal cancer syndromes: Molecular genetics, genetic counseling, diagnosis and management
-
Lynch HT, Lynch JF, Lynch PM, Attard T. Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer 2008;7:27-39.
-
(2008)
Fam Cancer
, vol.7
, pp. 27-39
-
-
Lynch, H.T.1
Lynch, J.F.2
Lynch, P.M.3
Attard, T.4
-
9
-
-
4444311092
-
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing
-
DOI 10.1136/jmg.2004.020651
-
Domingo E, Laiho P, Ollikainen M, et al. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 2004;41:664-668. (Pubitemid 39208606)
-
(2004)
Journal of Medical Genetics
, vol.41
, Issue.9
, pp. 664-668
-
-
Domingo, E.1
Laiho, P.2
Ollikainen, M.3
Pinto, M.4
Wang, L.5
French, A.J.6
Westra, J.7
Frebourg, T.8
Espin, E.9
Armengol, M.10
Hamelin, R.11
Yamamoto, H.12
Hofstra, R.M.W.13
Seruca, R.14
Lindblom, A.15
Peltomaki, P.16
Thibodeau, S.N.17
Aaltonen, L.A.18
Schwartz Jr., S.19
-
10
-
-
34547405167
-
Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer
-
DOI 10.1007/s10689-007-9124-1
-
Loughrey MB, Waring PM, Tan A, et al. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary nonpolyposis colorectal cancer. Fam Cancer 2007;6:301-310. (Pubitemid 47175009)
-
(2007)
Familial Cancer
, vol.6
, Issue.3
, pp. 301-310
-
-
Loughrey, M.B.1
Waring, P.M.2
Tan, A.3
Trivett, M.4
Kovalenko, S.5
Beshay, V.6
Young, M.-A.7
McArthur, G.8
Boussioutas, A.9
Dobrovic, A.10
-
11
-
-
58249089525
-
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
-
Ogino S, Nosho K, Kirkner GJ, et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut 2009;58:90-96.
-
(2009)
Gut
, vol.58
, pp. 90-96
-
-
Ogino, S.1
Nosho, K.2
Kirkner, G.J.3
-
12
-
-
77954720070
-
Clinical relevance of microsatellite instability in colorectal cancer
-
de la Chapelle A, Hampel H. Clinical relevance of microsatellite instability in colorectal cancer. J Clin Oncol 2010;28:3380-3387.
-
(2010)
J Clin Oncol
, vol.28
, pp. 3380-3387
-
-
De La Chapelle, A.1
Hampel, H.2
-
13
-
-
77950812741
-
Anaplastic lymphoma kinase as a therapeutic target in anaplastic large cell lymphoma, non-small cell lung cancer and neuroblastoma
-
Cheng M, Ott GR. Anaplastic lymphoma kinase as a therapeutic target in anaplastic large cell lymphoma, non-small cell lung cancer and neuroblastoma. Anticancer Agents Med Chem 2010;10:236-249.
-
(2010)
Anticancer Agents Med Chem
, vol.10
, pp. 236-249
-
-
Cheng, M.1
Ott, G.R.2
-
14
-
-
68649121646
-
The RASopathies: Developmental syndromes of Ras/MAPK pathway dysregulation
-
Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 2009;19: 230-236.
-
(2009)
Curr Opin Genet Dev
, vol.19
, pp. 230-236
-
-
Tidyman, W.E.1
Rauen, K.A.2
|